Micrographic surgery of skin cancer in German hospitals 2005-2006
Authors:
- 4 March 2011
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 25 (4) , 422-428
Abstract
Surgical therapy of skin cancer includes conventional wide excision and micrographic surgery (MS). Little is known about the population-wide spread of MS for the treatment of skin cancer. The aim was to estimate the in-hospital use of MS for the treatment of skin cancer in Germany. We used nationwide DRG data from 2005 through 2006. We identified hospitalizations with a main diagnosis of cutaneous malignant melanoma (CMM) (ICD-10: C43) or non-melanoma skin cancer (NMSC) (ICD-10: C44). MS was identified by OPS procedure codes including 5-895.1, 5-895.3, 5-212.1, 5-181.1, 5-181.4, 5-181.6, 5-182.1, 5-091.1, or 5-091.3. We identified 52 660 and 98 484 hospitalizations with a primary diagnosis of CMM and NMSC respectively; 54.6% and 36.5% of NMSC and CMM-related admissions with local skin cancer treatment included MS. The relative frequency of MS varied by anatomic subsite of the skin cancer and by region of the hospital. Local infections were the most frequent complications after MS with 3.2-4.0% for NMSC and 2.3-2.9% for CMM followed by haemorrhages. Dehiscence of the operation wound is a rare event with risks ranging between 0.1% and 0.3%. Micrographic surgery is frequently used for the local treatment of NMSC and varies considerably across Federal States of Germany. It is difficult to speculate how many MS might be performed in private or ambulatory settings in Germany. As MS requires surgical expertise, technical support and dermatopathology, we speculate that MS is much less frequently undertaken in private practices in Germany.Keywords
This publication has 31 references indexed in Scilit:
- Inpatient management of patients with skin cancer in Germany: an analysis of the nationwide DRG-statistic 2005-2006British Journal of Dermatology, 2009
- Mohs Micrographic SurgeryDermatologic Surgery, 2009
- Surgical excision versus Mohs' micrographic surgery for primary and recurrent basal-cell carcinoma of the face: a prospective randomised controlled trial with 5-years' follow-upThe Lancet Oncology, 2008
- Variation in Care for Recurrent Nonmelanoma Skin Cancer in a University-Based Practice and a Veterans Affairs ClinicArchives of Dermatology, 2008
- Malignant melanoma and nonmelanoma skin cancers in Northrhine‐Westphalia, Germany: a patient‐ vs. diagnosis‐based incidence approachInternational Journal of Dermatology, 2007
- Basal cell carcinoma treated with Mohs surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005
- Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005
- Cosmetic results of histographically controlled excision of non-melanoma skin cancer in the head and neck region. Asthetische Ergebnisse nach histographisch kontrollierter Exzision maligner Tumoren im Kopf- und HalsbereichJDDG: Journal der Deutschen Dermatologischen Gesellschaft, 2005
- Site- and gender-specific time trend analyses of the incidence of skin melanomas in the former German Democratic Republic (GDR) including 19 351 casesEuropean Journal of Cancer, 2003
- Mohs micrographic surgeryJournal of the American Academy of Dermatology, 1998